PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma
Glaucoma can cause irreversible vision loss and blindness. Current medications require multiple daily applications and have side effects like redness and stinging of the eyes.
PharmaDrug (PHRX) wants to develop a superior treatment using analogues of DMT.
The company discovered that the compounds can “activate protective pathways within critical cellular compartments of the eye” to reduce pressure inside the eye.
PharmaDrug will collaborate with the Terasaki Institute for Biomedical Innovation to produce a device that can deliver low doses of the drug to the front of the eye.
